000 01345 a2200373 4500
005 20250516023716.0
264 0 _c20110607
008 201106s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.200
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaraboletti, Giulia
245 0 0 _aTargeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors.
_h[electronic resource]
260 _bOncotarget
_cNov 2010
300 _a662-673 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAngiogenesis Inhibitors
_xchemical synthesis
650 0 4 _aAnimals
650 0 4 _aBiomimetics
_xmethods
650 0 4 _aDrug Design
650 0 4 _aHumans
650 0 4 _aModels, Biological
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aNeoplasms
_xblood supply
650 0 4 _aNeovascularization, Pathologic
_xdrug therapy
650 0 4 _aRationalization
650 0 4 _aThrombospondin 1
_xchemistry
700 1 _aRusnati, Marco
700 1 _aRagona, Laura
700 1 _aColombo, Giorgio
773 0 _tOncotarget
_gvol. 1
_gno. 7
_gp. 662-673
856 4 0 _uhttps://doi.org/10.18632/oncotarget.200
_zAvailable from publisher's website
999 _c20594900
_d20594900